CEDIA Heroin Metabolite (6-AM) Assay
K-Number: K231007 · 2023-09-27
Device Summary
Frequently Asked Questions
What is the CEDIA Heroin Metabolite (6-AM) Assay?
CEDIA Heroin Metabolite (6-AM) Assay is a medical device that received FDA 510(k) clearance on 2023-09-27. The listed applicant is Microgenics Corporation. The 510(k) number is K231007.
When did CEDIA Heroin Metabolite (6-AM) Assay receive FDA 510(k) clearance?
CEDIA Heroin Metabolite (6-AM) Assay received FDA 510(k) clearance on 2023-09-27, under 510(k) number K231007.
Who is the listed applicant for CEDIA Heroin Metabolite (6-AM) Assay?
The FDA 510(k) record lists Microgenics Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CEDIA Heroin Metabolite (6-AM) Assay?
The FDA product code for CEDIA Heroin Metabolite (6-AM) Assay is DJG.
Other records listing Microgenics Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DJG)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.